LBTD (Lotus Bio-Technology Development) EBITDA Margin %: 0.00% (As of Dec. 2017)


What is Lotus Bio-Technology Development EBITDA Margin %?

Lotus Bio-Technology Development LBTD -99.99% EBITDA Margin % is 0.00% as of Dec. 2017.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lotus Bio-Technology Development's EBITDA for the three months ended in Dec. 2017 was $-0.00 Mil. Lotus Bio-Technology Development's Revenue for the three months ended in Dec. 2017 was $0.00 Mil. Therefore, Lotus Bio-Technology Development's EBITDA margin for the quarter that ended in Dec. 2017 was 0.00%.

Lotus Bio-Technology Development  (OTCPK:LBTD) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Lotus Bio-Technology Development EBITDA Margin % Related Terms

Lotus Bio-Technology Development EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development EBITDA Margin % Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LBTD vs SNES, CVAT: EBITDA Margin % Comparison

For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lotus Bio-Technology Development EBITDA Margin % vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Lotus Bio-Technology Development's EBITDA Margin % falls into.


Lotus Bio-Technology Development EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Lotus Bio-Technology Development's EBITDA Margin % for the fiscal year that ended in Mar. 2017 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2017 )/Revenue (A: Mar. 2017 )
=-0.02/0
= %

Lotus Bio-Technology Development's EBITDA Margin % for the quarter that ended in Dec. 2017 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2017 )/Revenue (Q: Dec. 2017 )
=-0.001/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Lotus Bio-Technology Development (LBTD) has a EBITDA Margin % of 0.00% as of Dec. 2017. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's EBITDA Margin % too high?
Lotus Bio-Technology Development's current EBITDA Margin % is 0.00%.
How does Lotus Bio-Technology Development's EBITDA Margin % compare to SNES and CVAT?
Lotus Bio-Technology Development's EBITDA Margin % of 0.00% can be compared against companies in the Agriculture industry. The industry median EBITDA Margin % is 9.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.63, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lotus Bio-Technology Development and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Bio-Technology Development's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current EBITDA Margin % is 0.00% as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.